A new hope for early gonarthrosis treatment using a biotechnological therapeutic drug to regenerate cartilage by intra-articular knee injection

Deliverables

Documents, reports (4)

Report on volunteers recruitment and clinical trial launch

Copy of CTA folder

Ethical protocols reports and authorization approval copies

Report to present RHYP corporate identity and first leaflet and promotion material models

Publications

Peer reviewed articles (1)

REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis

Author(s): Rodrick Montjean, Sonia Escaich, Raffaello Paolini, Claude Carelli, Sébastien Pirson, Thibaut Neutelings, Yves Henrotin, Christelle Vêtu
Published in: PLOS ONE, 15/4, 2020, Page(s) e0231240, ISSN 1932-6203
Publisher: Public Library of Science
DOI: 10.1371/journal.pone.0231240